We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ESSA Pharma Inc | NASDAQ:EPIX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.07 | -1.01% | 6.88 | 4.57 | 11.00 | 7.70 | 6.74 | 7.03 | 13,725 | 05:00:09 |
| Prospectus Supplement | | | |||||
| | | | | S-1 | | | |
| | | | | S-2 | | | |
| | | | | S-7 | | | |
| | | | | S-8 | | | |
| | | | | S-12 | | | |
| | | | | S-18 | | | |
| | | | | S-19 | | | |
| | | | | S-20 | | | |
| | | | | S-22 | | | |
| | | | | S-26 | | | |
| | | | | S-29 | | | |
| | | | | S-29 | | | |
| | | | | S-30 | | | |
| | | | | S-31 | | | |
| | | | | S-31 | | | |
| Prospectus | | | | | | | |
| | | | | 1 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 11 | | | |
| | | | | 12 | | | |
| | | | | 13 | | | |
| | | | | 14 | | | |
| | | | | 15 | | | |
| | | | | 16 | | | |
| | | | | 28 | | | |
| | | | | 29 | | | |
| | | | | 31 | | | |
| | | | | 32 | | | |
| | | | | 33 | | | |
| | | | | 34 | | | |
| | | | | 35 | | | |
| | | | | 36 | | | |
| | | | | 37 | | | |
| | | | | 37 | | | |
| | | | | 37 | | |
| | |
Year Ended September 30,
|
| |
Three Months Ended December 31,
|
| ||||||||||||||||||||||||
| | |
2017
|
| |
2018
|
| |
2019
|
| |
2018
|
| |
2019
|
| |||||||||||||||
Highest rate during the period
|
| | | | 1.3743 | | | | | | 1.3310 | | | | | | 1.3642 | | | | | | 1.3642 | | | | | | 1.3330 | | |
Lowest rate during the period
|
| | | | 1.2128 | | | | | | 1.2288 | | | | | | 1.2803 | | | | | | 1.2803 | | | | | | 1.2988 | | |
Average exchange rate for the period(1)
|
| | | | 1.3140 | | | | | | 1.2835 | | | | | | 1.3269 | | | | | | 1.3204 | | | | | | 1.3200 | | |
Rate at the end of the period
|
| | | | 1.2480 | | | | | | 1.2945 | | | | | | 1.3243 | | | | | | 1.3642 | | | | | | 1.2988 | | |
|
Assumed public offering price per share
|
| | | $ | 3.98 | | |
|
Net tangible book value per share at December 31, 2019
|
| | | $ | 2.21 | | |
|
Increase in net tangible book value per share attributable to the offering
|
| | | $ | 0.47 | | |
|
As adjusted net tangible book value per share after giving effect to the offering
|
| | | $ | 2.68 | | |
|
Dilution in net tangible book value per share to new investors in this offering
|
| | | $ | 1.30 | | |
| | | | | 1 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 11 | | | |
| | | | | 12 | | | |
| | | | | 13 | | | |
| | | | | 14 | | | |
| | | | | 15 | | | |
| | | | | 16 | | | |
| | | | | 28 | | | |
| | | | | 29 | | | |
| | | | | 31 | | | |
| | | | | 32 | | | |
| | | | | 33 | | | |
| | | | | 34 | | | |
| | | | | 35 | | | |
| | | | | 36 | | | |
| | | | | 37 | | | |
| | | | | 37 | | | |
| | | | | 37 | | |
| | |
Year Ended September 30,
|
| |||||||||||||||
| | |
2015
|
| |
2016
|
| |
2017
|
| |||||||||
Low
|
| | | | 0.7455 | | | | | | 0.6854 | | | | | | 0.7276 | | |
High
|
| | | | 0.8980 | | | | | | 0.7972 | | | | | | 0.8245 | | |
Period End
|
| | | | 0.7466 | | | | | | 0.7624 | | | | | | 0.8013 | | |
Average
|
| | | | 0.8136 | | | | | | 0.7565 | | | | | | 0.7626 | | |
| | |
Last Six Months
|
| |||||||||||||||||||||||||||||||||
| | |
January
|
| |
February
|
| |
March
|
| |
April
|
| |
May
|
| |
June
|
| ||||||||||||||||||
Low
|
| | | | 0.7978 | | | | | | 0.7807 | | | | | | 0.7641 | | | | | | 0.7747 | | | | | | 0.7680 | | | | | | 0.7513 | | |
High
|
| | | | 0.8135 | | | | | | 0.8138 | | | | | | 0.7794 | | | | | | 0.7967 | | | | | | 0.7828 | | | | | | 0.7744 | | |
End of Month
|
| | | | 0.8135 | | | | | | 0.7807 | | | | | | 0.7756 | | | | | | 0.7791 | | | | | | 0.7723 | | | | | | 0.7594 | | |
For the month ended
|
| |
High (C$)(1)
|
| |
Low (C$)(1)
|
| ||||||
January 2018
|
| | | | 6.20 | | | | | | 5.00 | | |
February 2018
|
| | | | 6.20 | | | | | | 4.70 | | |
March 2018
|
| | | | 6.00 | | | | | | 4.10 | | |
April 2018
|
| | | | 5.55 | | | | | | 3.01 | | |
May 2018
|
| | | | 7.15 | | | | | | 4.00 | | |
June 2018
|
| | | | 5.98 | | | | | | 4.07 | | |
July 2018(2) | | | | | 5.45 | | | | | | 4.86 | | |
For the month ended
|
| |
High (US$)(1)
|
| |
Low (US$)(1)
|
| ||||||
January 2018
|
| | | | 5.00 | | | | | | 4.00 | | |
February 2018
|
| | | | 5.04 | | | | | | 3.60 | | |
March 2018
|
| | | | 5.00 | | | | | | 2.67 | | |
April 2018
|
| | | | 5.10 | | | | | | 2.00 | | |
May 2018
|
| | | | 5.83 | | | | | | 3.02 | | |
June 2018
|
| | | | 4.69 | | | | | | 3.45 | | |
July 2018(2) | | | | | 4.49 | | | | | | 3.76 | | |
For the quarter ended
|
| |
High (C$)
|
| |
Low (C$)
|
| ||||||
December 31, 2017
|
| | | | 9.00 | | | | | | 4.40 | | |
March 31, 2018
|
| | | | 6.20 | | | | | | 4.10 | | |
June 30, 2018
|
| | | | 7.15 | | | | | | 3.01 | | |
For the quarter ended
|
| |
High (US$)
|
| |
Low (US$)
|
| ||||||
December 31, 2017
|
| | | | 9.80 | | | | | | 3.00 | | |
March 31, 2018
|
| | | | 5.04 | | | | | | 2.67 | | |
June 30, 2018
|
| | | | 5.83 | | | | | | 2.00 | | |
|
SEC registration fee
|
| |
US$ 12,450
|
|
|
FINRA fee
|
| |
US$ 15,500
|
|
|
Legal fees and expenses
|
| |
US$ 60,000
|
|
|
Accounting fees and expenses
|
| |
US$ 5,000
|
|
|
Printing fees and expenses
|
| |
US$ 20,000
|
|
|
Miscellaneous
|
| |
US$ 5,000
|
|
|
Total
|
| |
US$117,950
|
|
1 Year ESSA Pharma Chart |
1 Month ESSA Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions